Recent Blog Posts

View Post: Loxapine (Loxapine Succinate) Drug Information: Uses, Side Effects ...
19 Aug 2008
Loxapine Capsules USP are indicated for the treatment of schizophrenia. The efficacy of loxapine in schizophrenia was established in clinical studies which enrolled newly hospitalized and chronically hospitalized acutely ill schizophrenic ..... Absorption of loxapine following oral or parenteral administration is virtually complete. The drug is removed rapidly from the plasma and distributed in tissues. Animal studies suggest an initial preferential distribution in lungs, ...
View Blog: RxList - News and Features - http://www.rxlist.com/script/main/hp.asp

---

View Post: Alexza Pharmaceuticals, Inc. Completes Enrollment in Phase 2a ...
30 Apr 2008
Oral formulations of drugs like alprazolam are approved for chronic use to treat panic disorder. These drugs are intended to reduce the frequency of panic attacks, but they do not typically eliminate their occurrence. ... Alexza's lead program, AZ-004 (Staccato loxapine) for the treatment of acute agitation in schizophrenic or bipolar disorder patients, is in Phase 3 testing. AZ-001 (Staccato prochlorperazine) for the acute treatment of migraine headaches has completed ...
View Blog: BioSpace.com Featured News and Stories - http://www.biospace.com/

---

View Post: Alexza's AZ-004 (Staccato Loxapine) Meets Primary Endpoint of ...
10 Dec 2008
Agitation is currently treated with injectable and oral anti-psychotic medications: the oral medications work relatively slowly and while the intramuscular injections have a faster onset of action, they are invasive and can be frightening to patients. The American Association of ... Alexza's lead program, AZ-004 (Staccato loxapine) for the acute treatment of agitation in schizophrenic or bipolar disorder patients, has completed both of the planned Phase 3 clinical trials. ...
View Blog: Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html

---

View Post: alexza's az-004 (staccato(r) loxapine) phase 3 trial meets primary ...
2 Sep 2008 by Rx Times  
oral hypoaesthesia 0 % 1 % 4 % headache 14 % 3 % 3 % somnolence 3 % 3 % 3 % nausea 5 % 1 % 2 % vomiting 3 % 1 % 1 % agitation 3 % 1 % 0 %. there were two serious adverse events reported during the trial: exacerbation of schizophrenia (1 ...
View Blog: Rx Times Pharmacy Magazine - Pharmacy Jobs,... - http://www.rxtimes.com/

---

View Post: loxitane teaching
6 May 2008 by jackal08  
loxapine / loxitane / loxapac. loxitane without a prescription from certified pharmacy. loxitane, major medical loxitane, buy loxitane, cheapest extent for usa . medlineplus drug information: loxapine oral. cheap loxitane. ...
View Blog: Blog about: Health - http://jackal08.wordpress.com/

---

View Post: alexza's az-104 (staccato(r) loxapine) phase 2a trial meets ...
3 Mar 2008 by Search  
agitation in patients with schizophrenia or bipolar disorder. az-004 and. az-104 are being developed through symphony allegro, a development collaboration formed between alexza and symphony capital in 2006. "loxapine is a potent ...
View Blog: News - http://www.yourseoconsulting.com/news/

---

View Post: the alexza begins first phase 3 clinical trial for az - 004 ...
1 Apr 2008 by cwanger001@massy.com  
loxapine az - 004 (staccato(r)). az - 004 is one candidate of products of inhalation that is developed for the treatment of acute agitation in the patients with the schizophrenia or the bipolar agitation. the alexza considers news, ...
View Blog: The latest Bipolar News - http://bipolar.everblogz.com/

---

View Post: alexza initiates first phase 3 clinical trial for az-004 (staccato ...
26 Feb 2008 by drugstorenews  
alexza's lead program, az-004 (staccato loxapine) for the treatment of acute agitation in schizophrenic or bipolar disorder patients, is in phase 3 testing. az-001 (staccato prochlorperazine) for the acute treatment of migraine ...
View Blog: Drugstorenews's Weblog - http://drugstorenews.wordpress.com/

---

View Post: alexza initiates first phase 3 clinical trial for az-004 (staccato ...
17 Mar 2008 by Jenege  
az-004 (staccato(r) loxapine). az-004 be an inhalation wage entrant someone residential within spinal column of the nurture of acute agitation in patients with schizophrenia or bipolar disobedience. alexza believe the innovative, ...
View Blog: No Slepping Problem - http://noslepping.blogspot.com/

---

View Post: alexza's az-004 (staccato(r) loxapine) meets primary endpoint of ...
9 Dec 2008
from our first phase 3 trial in schizophrenic patients -- reinforce our belief that az-004 is a potentially important new drug candidate for treating acute agitation. loxapine is a well established antipsychotic and the staccato ...
View Blog: PR SEO - RSS Feed - http://pr-seo.org/press-release-central-pacific-financial-corp-to-receive-135...

---